Leo Fondet 2024 AR2
The report highlights the LEO Foundation's activities and financial performance for 2024, marking its 40th anniversary. The LEO Group achieved a net profit of DKK 303 million, driven by a solid 13.3% return on the Foundation's financial investments, which reached DKK 18.3 billion. Majority-owned LEO Pharma delivered 10% organic revenue growth, driven by its dermatology portfolio, and launched Anzupgo in its first European markets. Philanthropically, the Foundation awarded DKK 275 million across 75 grants to support independent skin research, including a special anniversary prize. Additionally, the Group prepared for CSRD compliance by conducting its first double materiality assessment.
Company: Leo Fondet
Sector: Finance & insurance
Country: Denmark
Year: 2024
Type: AR2
Pages: 98
Leo Fondet
The report highlights the LEO Foundation's activities and financial performance for 2024, marking its 40th anniversary. The LEO Group achieved a net profit of DKK 303 million, driven by a solid 13.3% return on the Foundation's financial investments, which reached DKK 18.3 billion. Majority-owned LEO Pharma delivered 10% organic revenue growth, driven by its dermatology portfolio, and launched Anzupgo in its first European markets. Philanthropically, the Foundation awarded DKK 275 million across 75 grants to support independent skin research, including a special anniversary prize. Additionally, the Group prepared for CSRD compliance by conducting its first double materiality assessment.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Net Zero Target
Employees